Impedans

BiotechnologySeries BDublin, Irelandimpedans.com

Latest round

Series B

Last raised

Nov 2021

Total raised

$4.5M

Investors

3

About Impedans

Founded in 2004 and headquartered in Dublin, Ireland, Impedans focuses on providing advanced diagnostic tools for plasma technology.865 mn.Impedans Ltd specializes in high-precision sensors and diagnostic solutions in plasma technology, catering to a diverse clientele that includes semiconductor manufacturers, university research institutes, and plasma equipment makers. Their core products encompass various advanced measurement tools, such as Langmuir probes for assessing fundamental plasma parameters, RF Voltage-Current (VI) probes for analyzing power and impedance, and the Semion series for substrate-level measurements and ion flux characterization. These products facilitate real-time monitoring and optimization of plasma processes across industries like semiconductor manufacturing, aerospace, and medical technology. By providing invaluable data on plasma behavior, Impedans's solutions enable their clients to enhance equipment performance, streamline production processes, and achieve specific application requirements.Impedans Ltd engages in a business model that focuses on direct sales of its advanced diagnostic products to B2B clients, primarily within the semiconductor and plasma technology sectors. Their flagship products, including the Octiv VI probes and various Semion models, are critical in process development and equipment maintenance, forming the backbone of their sales strategy.4 in 2015, indicating operational challenges. However, their revenue generation is structured around individual transactions for specific products, as well as potential recurring revenue through maintenance services and calibration solutions.50 mn, the company plans to invest in the development of new products and expand into emerging markets. Upcoming products are aimed at enhancing precision in plasma diagnostics, though specific release dates are not yet disclosed.

Who invested in Impedans

3 investors across 3 rounds

See all investors in Impedans

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 30, 2021

    Amount

    $4M

    Investors

    Locked

  2. Series A

    Feb 24, 2015

    Amount

    $0.6M

    Investors

    Locked

  3. Seed

    Jan 1, 2015

    Amount

    Undisclosed

    Investors

    Locked

Questions about Impedans

Who invested in Impedans?

Impedans has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Impedans raised?

Impedans has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Impedans last raise money?

Impedans's most recent round on record is a Series B, in Nov 2021.

What does Impedans do?

Founded in 2004 and headquartered in Dublin, Ireland, Impedans focuses on providing advanced diagnostic tools for plasma technology.

Where is Impedans headquartered?

Impedans is headquartered in Dublin, Ireland.

Which VCs invest in companies like Impedans?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Impedans's stage. Their profiles are linked below.

Raising like Impedans? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.